Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency
The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.
Abstract
Although the use of the insulin tolerance test (ITT) for the diagnosis of adult GH deficiency is well established, diagnostic peak GH cut-points for other commonly used GH stimulation tests are less clearly established. Despite that fact, the majority of patients in the United States who are evaluated for GH deficiency do not undergo insulin tolerance testing. The aim of this study was to evaluate the relative utility of six different methods of testing for adult GH deficiency currently used in practice in the United States and to develop diagnostic cut-points for each of these tests. Thirty-nine patients (26 male, 13 female) with adult-onset hypothalamic-pituitary disease and multiple pituitary hormone deficiencies were studied in comparison with age-, sex-, estrogen status-, and body mass index-matched control subjects (n = 34; 20 male, 14 female). A third group of patients (n = 21) with adult-onset hypothalamic-pituitary disease and no more than one additional pituitary hormone deficiency was also studied. The primary end-point was peak serum GH response to five GH stimulation tests administered in random order at five separate visits: ITT, arginine (ARG), levodopa (L-DOPA), ARG plus L-DOPA, and ARG plus GHRH. Serum IGF-I concentrations were also measured on two occasions. For purposes of analysis, patients with multiple pituitary hormone deficiencies were assumed to be GH deficient. Three diagnostic cut-points were calculated for each test to provide optimal separation of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While interpreting GH values, one should also consider multiple factors, including nutritional and hormonal status, exercise, body weight, and age, all of which may influence pituitary GH secretion (85,86).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [86]
Citations
Cites
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672 · cited 1×
“Each one unit increase in BMI has been shown to be associated with a 6% decrease in 24-h GH secretion (35).”
Background; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
VELDHUIS, J. D., IRANMANESH, A., HO, K. K. Y., WATERS, M. J., JOHNSON, M. L., & LIZARRALDE, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-51 · Cited by 480 · cited 1×
“Obesity suppresses GH release, with 24-h GH levels in obese men reduced by 75% in comparison with age-matched normal weight subjects (34).”
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414 · cited 4×
“Therefore, evaluation of tests designed to diagnose GHD should control for such variables (18, 19).”
BackgroundInfluentialDiagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-690 · Cited by 352 · cited 1×
“GH therapy was not administered for at least one month before study entry, based on data that demonstrate that serum IGF-I levels return to nearbaseline within 48 h after cessation of GH (22).”
MethodArginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*
ALBA-ROTH, J., MÜLLER, O. A., SCHOPOHL, J., & WERDER, K. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1186 · Cited by 337 · cited 1×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
Background
Research works printed but not linked: 2
- 1998, AACE clinical practice guidelines for growth hormone use in adults and children., Endocr Pract, 4, 165
- Mausner, 1974, Epidemiology, Philadelphia: W. B. Saunders;, 237
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
“(37), however, because the average BMI of their patients”
InfluentialHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Self-citationGrimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., Murad, M. H., & on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) · Hormone Research in Paediatrics · doi:10.1159/000452150 · Cited by 697
“The insulin tolerance test (ITT) has been validated for the diagnosis of adult GHD [20,168] and persistent”
BackgroundMethodInfluentialMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., Shalet, S. M., Vance, M. L., & for The Endocrine Society’s Clinical Guidelines Subcommittee (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2227 · Cited by 424
Anterior Pituitary Dysfunction in Survivors of Traumatic Brain Injury
Agha, A., Rogers, B., Sherlock, M., O’Kelly, P., Tormey, W., Phillips, J., & Thompson, C. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0511 · Cited by 390
Bredella, M. A., Torriani, M., Ghomi, R. H., Thomas, B. J., Brick, D. J., Gerweck, A. V., Rosen, C. J., Klibanski, A., & Miller, K. K. (2011) · Obesity · doi:10.1038/oby.2010.106 · Cited by 348
“5 g/kg (maximum 30 g) IV were administered and GH levels drawn at baseline and every 30 min for 2 h, the standard protocol used to diagnose GH deficiency in patients with hypopituitarism (23).”
MethodAimaretti, G., Ambrosio, M. R., Di Somma, C., Fusco, A., Cannavò, S., Gasperi, M., Scaroni, C., De Marinis, L., Benvenga, S., Uberti, E. C. D., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02094.x · Cited by 339
“the so called gold standard test (= 5·0 μg/l); (c) the 1st centile limit of normal response to ITT test (= 3·0 μg/l); severe GHD is demonstrated by ITT test below this limit (Ghigo et al., 2001; Hoffman et al., 1994; Biller et al., 2002).”
BackgroundSchneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Occurrence of pituitary dysfunction following traumatic brain injury
Bondanelli, M., De Marinis, L., Ambrosio, M. R., Monesi, M., Valle, D., Zatelli, M. C., Fusco, A., Bianchi, A., Farneti, M., & Degli, E. C. I. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041269713 · Cited by 322
Corneli, G., Di Somma, C., Baldelli, R., Rovere, S., Gasco, V., Croce, C. G., Grottoli, S., Maccario, M., Colao, A., Lombardi, G., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01967 · Cited by 317
“This cut-off is lower than that we found, but control subjects studied by Biller et al. ( 34 ) had a higher body mass index (BMI; 30.3^5.8kg/m2).”
BackgroundMethodResultInfluentialMisra, M., Miller, K. K., Almazan, C., Ramaswamy, K., Lapcharoensap, W., Worley, M., Neubauer, G., Herzog, D. B., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0723 · Cited by 316
“An example is the increase in cortisol and GH after insulin-induced hypoglycemia, which is the basis for assessing adequacy of GH and cortisol secretion using the insulin tolerance test (40, 41).”
MethodGurney, J. G., Ness, K. K., Sibley, S. D., O'Leary, M., Dengel, D. R., Lee, J. M., Youngren, N. M., Glasser, S. P., & Baker, K. S. (2006) · Cancer · doi:10.1002/cncr.22120 · Cited by 312
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Self-citationWilson, T. A., Rose, S. R., Cohen, P., Rogol, A. D., Backeljauw, P., Brown, R., Hardin, D. S., Kemp, S. F., Lawson, M., Radovick, S., et al. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00246-4 · Cited by 249
“Although there is little information on this issue in adolescents with GH deficiency who have completed growth, current data suggest that when the diagnosis of adult GHD is established, resumption or continuation of GH therapy is recommended to achieve optimal body composition, lipid profile, and cardiac function.(65,…”
Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury
Schneider, H. J., Schneider, M., Saller, B., Petersenn, S., Uhr, M., Husemann, B., von Rosen, F., & Stalla, G. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02071 · Cited by 224
“It has been shown that this test might be BMI dependent, and a cutoff of 4.3 ng/ml has been suggested, derived from a sample of subjects with a mean BMI of . 30 ( 25 ).”
MethodInfluentialPituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Hypopituitarism after traumatic brain injury
Bondanelli, M., Ambrosio, M. R., Zatelli, M. C., De Marinis, L., & Uberti, E. C. D. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01895 · Cited by 208
“The current consensus is that patients with appropriate clinical history should have the diagnosis of GHD confirmed by a provocative test of GH secretion ( 89 , 90).”
BackgroundInfluentialDarzy, K. H., Aimaretti, G., Wieringa, G., Gattamaneni, H. R., Ghigo, E., & Shalet, S. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021094 · Cited by 182
“More recently, a much lower peak GH response ( 5 g/liter) to the combined GHRH AST was recommended to maximize specificity for the diagnosis of severe GHD (45).”
BackgroundNon-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
Esposito, D., Olsson, D. S., Ragnarsson, O., Buchfelder, M., Skoglund, T., & Johannsson, G. (2019) · Pituitary · doi:10.1007/s11102-019-00960-0 · Cited by 177
Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s2.1 · Cited by 179
Self-citationPrevalence and predictive factors of post-traumatic hypopituitarism
Klose, M., Juul, A., Poulsgaard, L., Kosteljanetz, M., Brennum, J., & Feldt‐Rasmussen, U. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02860.x · Cited by 176
Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults
Melmed, S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1817346 · Cited by 173
Misra, M., Bredella, M. A., Tsai, P., Mendes, N., Miller, K. K., & Klibanski, A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00052.2008 · Cited by 161
Hypopituitarism following radiotherapy
Darzy, K. H., & Shalet, S. M. (2009) · Pituitary · doi:10.1007/s11102-008-0088-4 · Cited by 161
“63–65]; with similar or even increased GH responses to the GHRH + AST compared with normal men [54, 62, 66].”
BackgroundKelly, D. F., McArthur, D. L., Levin, H., Swimmer, S., Dusick, J. R., Cohan, P., Wang, C., & Swerdloff, R. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.928 · Cited by 158
“We (Qu et al, 2005) and others (Biller et al., 2002) have previously demonstrated a negative correlation between BMI and GH response to provocative stimuli.”
Link, K., Moëll, C., Garwicz, S., Cavallin-Ståhl, E. K., Björk, J., Thilén, U., Åhrén, B., & Erfurth, E. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0126 · Cited by 155
Radiation-induced hypopituitarism after cancer therapy: who, how and when to test
Darzy, K. H. (2009) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1051 · Cited by 171
Ness, K. K., Baker, K. S., Dengel, D. R., Youngren, N., Sibley, S., Mertens, A. C., & Gurney, J. G. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21091 · Cited by 144
“[47] GH levels were obtained at 30, 40, 60, 90, and 120 min following a 1.”
MethodKlose, M., Juul, A., Struck, J., Morgenthaler, N. G., Kosteljanetz, M., & Feldt‐Rasmussen, U. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02931.x · Cited by 142
Hypopituitarism following Radiotherapy Revisited
Darzy, K. H., & Shalet, S. M. (2009) · Endocrine development · doi:10.1159/000207607 · Cited by 141
Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage
Kreitschmann-Andermahr, I., Hoff, C., Saller, B., Niggemeier, S., Pruemper, S., Hütter, B. O., Rohde, V., Gressner, A., Matern, S., & Gilsbach, J. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0146 · Cited by 134
“It is well known that obesity might influence the results from GH stimulation tests, even from the ITT, and may cause an overestimation of the prevalence of GHD in an overweight population (20, 25).”
BackgroundFleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 141
Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement
Reed, M. L., Merriam, G. R., & Kargi, A. Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00064 · Cited by 119
“Because it induces hypoglycemia, it is contraindicated in patients with coronary artery disease, seizures, and in the elderly (Biller et al., 2002).”
BackgroundBonert, V. S., Elashoff, J. D., Barnett, P., & Melmed, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032213 · Cited by 117
“The evoked GH response to insulin-induced hypoglycemia (determined by ITT) has been the standard GH provocative test (13, 15, 16).”
BackgroundMethodInfluentialSelf-citationMacimorelin as a Diagnostic Test for Adult GH Deficiency
Garcia, J. M., Biller, B. M. K., Korbonits, M., Popovic, V., Luger, A., Strasburger, C. J., Chanson, P., Medic-Stojanoska, M., Schopohl, J., Zakrzewska, A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00665 · Cited by 105
Self-citationGH/IGF-I Regulation in Obesity – Mechanisms and Practical Consequences in Children and Adults
Kreitschmann-Andermahr, I., Suarez, P., Jennings, R., Evers, N., & Brabant, G. (2010) · Hormone Research in Paediatrics · doi:10.1159/000284355 · Cited by 117
“To our knowledge, test reproducibility, specifically in obese subjects, has never been a matter of investigation. So far, a systematic comparison of the various tests was only performed in cross-sectional studies or in small series of patients with pituitary deficiency. In a very detailed but small analysis, Biller et…”
ResultQu, X.-D., Gaw Gonzalo, I. T., Al Sayed, M. Y., Cohan, P., Christenson, P. D., Swerdloff, R. S., Kelly, D. F., & Wang, C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1450 · Cited by 103
Maghnie, M., Aimaretti, G., Bellone, S., Bona, G., Bellone, J., Baldelli, R., de Sanctis, C., Gargantini, L., Gastaldi, R., Ghizzoni, L., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01873 · Cited by 101
“Therefore, the discrepancy between our results and those reported by Hoffman et al. (12) and Biller et al. ( 13 ), can be explained by the subjects’ age difference or by their different etiology of GHD.”
InfluentialColao, A., Di Somma, C., Cuocolo, A., Filippella, M., Rota, F., Acampa, W., Savastano, S., Salvatore, M., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1042 · Cited by 103
Laboratory measurement of growth hormone
Popii, V., & Baumann, G. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.06.007 · Cited by 100
Beauregard, C., Utz, A. L., Schaub, A. E., Nachtigall, L., Biller, B. M. K., Miller, K. K., & Klibanski, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2371 · Cited by 99
“Insulin tolerance and GHRH-arginine tests were performed as previously described (36).”
MethodSelf-citationA simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency
Chihara, K., Shimatsu, A., Hizuka, N., Tanaka, T., Seino, Y., Katofor, Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0066 · Cited by 98
“useful, reproducible, alternative test to the ITT (8, 9) .I t is not affected by age but by gender and adiposity ( 9 , 10).”
BackgroundApproach to the Growth Hormone-Deficient Child during Transition to Adulthood
Radovick, S., & DiVall, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0167 · Cited by 96
Dichtel, L. E., Yuen, K. C. J., Bredella, M. A., Gerweck, A. V., Russell, B. M., Riccio, A. D., Gurel, M. H., Sluss, P. M., Biller, B. M. K., & Miller, K. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2830 · Cited by 94
Self-citationDiagnosis of adult GH deficiency
Ghigo, E., Aimaretti, G., & Corneli, G. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.07.004 · Cited by 103
“Further agreement about the assumption that GHRH + ARG test is as reliable as ITT for the diagnosis of adult GHD comes from data from Biller and co-workers [22] who had normal control subjects matched to the pituitary patients for age, sex and even BMI.”
BackgroundMethodGrowth Hormone Therapy in Adults
Cummings, D. E., & Merriam, G. R. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152147 · Cited by 96
Diagnosis and treatment of growth hormone deficiency in adults
Kargi, A. Y., & Merriam, G. R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.77 · Cited by 95
De Bellis, A., Bizzarro, A., Conte, M., Perrino, S., Coronella, C., Solimeno, S., Sinisi, A. M., Stile, L. A., Pisano, G., & Bellastella, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021054 · Cited by 90
“0 g/liter, respectively, as previously described (28, 29) with our minor modifications.”
MethodRadiation-induced hypopituitarism
Fernandez, A., Brada, M., Zabuliene, L., Karavitaki, N., & Wass, J. A. H. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0231 · Cited by 84
“2005a) Sensitivity 89%, specificity 95% for a cutoff of 9 mU/l (Biller et al. 2002) in adult patients In the transition period, cut-offs of 15 mU/l (Clayton et al.”
BackgroundPituitary disease: presentation, diagnosis, and management
Levy, A. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.045740 · Cited by 93
“The peak GH secretory response to a bolus of GH releasing hormone (1 µg/kg) given at the beginning of a 30 minute infusion of arginine (0.5 g/kg) is a safer and more potent GH secretogogue than insulin induced hypoglycaemia.”
BackgroundInfluentialGarcia, J. M., Swerdloff, R., Wang, C., Kyle, M., Kipnes, M., Biller, B. M. K., Cook, D., Yuen, K. C. J., Bonert, V., Dobs, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1157 · Cited by 81
Self-citationYuen, K. C. J., Biller, B. M. K., Molitch, M. E., & Cook, D. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0299 · Cited by 84
“The diagnostic reliability of ARG alone has been previously questioned (5, 39).”
BackgroundMethodSelf-citationHypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage
Klose, M., Brennum, J., Poulsgaard, L., Kosteljanetz, M., Wagner, A., & Feldt‐Rasmussen, U. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03791.x · Cited by 81
Yuen, K. C. J., Johannsson, G., Ho, K. K. Y., Miller, B. S., Bergadá, I., & Rogol, A. D. (2023) · Endocrine Connections · doi:10.1530/ec-22-0504 · Cited by 97
Role and Importance of IGF-1 in Traumatic Brain Injuries
Mangiola, A., Vigo, V., Anile, C., BONIS, P. D., Marziali, G., & Lofrese, G. (2015) · BioMed Research International · doi:10.1155/2015/736104 · Cited by 81
“According to a multicenter study, which used a sensitive immunochemiluminescent two-site assay, this cut-point provides the best compromise in terms of specificity and sensitivity for the diagnosis of adult GH deficiency through theGHRH-arginine test, thusminimizing the misclassification of multiple pituitary hormone…”
MethodKlose, M., Stochholm, K., Janukonyté, J., Lehman Christensen, L., Frystyk, J., Andersen, M., Laurberg, P., Christiansen, J. S., & Feldt-Rasmussen, U. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2397 · Cited by 73
“6) Waist 102 cm (men) or 88 cm (women), n (%) 119 (27) 22 (18) Tests performed, n (%) ITT (single test) 29 (7) 0 (0) PD-GHRH (single test) 200 (45) 4 (3) GHRH-arg (single test) 37 (8) 1 (1) ITT plus PD-GHRH 156 (36) 79 (64) ITT plus GHRH-arg 15 (3) 31 (25) ITT plus PD-GHRH plus GHRH-arg 0 (0) 9 (7)”
Bone mineral density in young adult survivors of acute lymphoblastic leukemia
Thomas, I. H., Donohue, J. E., Ness, K. K., Dengel, D. R., Baker, K. S., & Gurney, J. G. (2008) · Cancer · doi:10.1002/cncr.23912 · Cited by 76
GPRC6A Mediates the Effects of l-Arginine on Insulin Secretion in Mouse Pancreatic Islets
Pi, M., Wu, Y., Lenchik, N. I., Gerling, I., & Quarles, L. D. (2012) · Endocrinology · doi:10.1210/en.2012-1301 · Cited by 74
Yuen, K. C. J., Tritos, N. A., Samson, S. L., Hoffman, A. R., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161407.dscr · Cited by 73
Boquete, H. R., Sobrado, P. G. V., Fideleff, H. L., Sequera, A. M., Giaccio, A. V., Suárez, M. G., Ruibal, G. F., & Miras, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030412 · Cited by 74
Leong, G. M., & Johannsson, G. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071231 · Cited by 74
Wexler, T., Gunnell, L., Omer, Z., Kuhlthau, K., Beauregard, C., Graham, G., Utz, A. L., Biller, B., Nachtigall, L., Loeffler, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2671 · Cited by 69
“0 NS History of GH-lowering medication 5 (45) 5 (26) NS Time since diagnosis of acromegaly 163.”
BackgroundMethodSelf-citationGH deficiency as the most common pituitary defect after TBI: clinical implications
Popovic, V. (2005) · Pituitary · doi:10.1007/s11102-006-6047-z · Cited by 68
“The situation is complicated by the availability of many provocation tests and many assays for its measurement [7].”
BackgroundColao, A., Di Somma, C., Savastano, S., Rota, F., Savanelli, M. C., Aimaretti, G., & Lombardi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1134 · Cited by 69
Growth Hormone Perturbations in Fibromyalgia: A Review
Jones, K. D., Deodhar, P., Lorentzen, A., Bennett, R. M., & Deodhar, A. A. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.09.006 · Cited by 81
The Neuroendocrine Effects of Traumatic Brain Injury
Rothman, M. S., Arciniegas, D. B., Filley, C. M., & Wierman, M. E. (2007) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19.4.363 · Cited by 68
Postoperative assessment of the patient after transsphenoidal pituitary surgery
Ausiello, J. C., Bruce, J. N., & Freda, P. U. (2008) · Pituitary · doi:10.1007/s11102-008-0086-6 · Cited by 76
“A recent study assessed six provocative tests of GH secretion and found the arginine/ GHRH test to be an excellent alternative to the ITT [ 44 ].”
BackgroundMiller, K. K., Wexler, T., Fazeli, P., Gunnell, L., Graham, G. J., Beauregard, C., Hemphill, L., Nachtigall, L., Loeffler, J., Swearingen, B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1611 · Cited by 66
Self-citationWebb, S. M., Mo, D., Lamberts, S. W. J., Melmed, S., Cavagnini, F., Pecori Giraldi, F., Strasburger, C. J., Zimmermann, A. G., Woodmansee, W. W., & on behalf of the International HypoCCS Advisory Board (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0806 · Cited by 64
Cranial Irradiation and Growth Hormone Neurosecretory Dysfunction: A Critical Appraisal
Darzy, K. H., Pezzoli, S. S., Thorner, M. O., & Shalet, S. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2599 · Cited by 62
“Furthermore, the greater attenuation in GH responses to the ITT compared with GHRH in many studies may not necessarily reflect reduced hypothalamic GHRH but rather underlying hypothalamic “hyperactivity,” which restrains further stimulation with the ITT, in exactly similar fashion to that which is seen in normal women…”
ResultCordido, F., Alvarez-Castro, P., Isidro, M., Casanueva, F., & Dieguez, C. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490117 · Cited by 62
Anterior Pituitary Hormone Abnormalities following Traumatic Brain Injury
Schneider, M., Schneider, H. J., & Stalla, G. K. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.937 · Cited by 61
“In a more recent study, using a newly developed method of GH measurement (chemoimmunolumines-cence) and a study population with a higher BMI (30.8 (cid:2) 5.6), a cut-off point of 4.1 (cid:1) g/L has been suggested (Biller et al., 2002).”
InfluentialWebb, S. M., Strasburger, C. J., Mo, D., Hartman, M. L., Melmed, S., Jung, H., Blum, W. F., Attanasio, A. F., & on behalf of the HypoCCS International Advisory Board (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0713 · Cited by 59
“Recent studies have demonstrated that different peak GH cutoff values for establishing the biochemical diagnosis of adult GHD are needed to optimize the sensitivity and specificity of each GH stimulation test (28, 30, 31).”
BackgroundMethodSelf-citationIdiopathic adult growth hormone deficiency
Melmed, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4012 · Cited by 58
“1 g/L, respectively, with a 96% sensitivity and 92% specificity as assessed by receiver operating characteristic analysis (32).”
MethodImpact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]
Giovannini, L., Tirabassi, G., Muscogiuri, G., Somma, C. D., Colao, A., & Balercia, G. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0337 · Cited by 64
Pituitary Physiology and Diagnostic Evaluation
Melmed, S. K., Kleinberg, D. L., & Ho, K. K. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00008-0 · Cited by 64
Self-citationAnterior hypopituitarism following traumatic brain injury
Urban, R. J., Harris, P., & Masel, B. (2005) · Brain Injury · doi:10.1080/02699050400004807 · Cited by 57
“This is also a recognized test for GH deficiency [23].”
BackgroundQuality of life and psychological well‐being in GH‐treated, adult PWS patients: a longitudinal study
Bertella, L., Mori, I., Grugni, G., Pignatti, R., Ceriani, F., Molinari, E., Ceccarelli, A., Sartório, A., Vettor, R., & Semenza, C. (2007) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00878.x · Cited by 60
Bredella, M. A., Torriani, M., Thomas, B. J., Ghomi, R. H., Brick, D. J., Gerweck, A. V., & Miller, K. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0438 · Cited by 58
Utz, A. L., Yamamoto, A., Hemphill, L., & Miller, K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0169 · Cited by 57
“GH levels drawn at baseline and every 30 min for 2 h] ( 21 ).”
BackgroundMethodInfluentialHigh Prevalence of Growth Hormone Deficiency in Severe Fibromyalgia Syndromes
Cuatrecasas, G., Gonzalez, M. J., Alegre, C., Sesmilo, G., Fernandez-Solà, J., Casanueva, F. F., Garcia-Fructuoso, F., Poca-Dias, V., Izquierdo, J. P., & Puig-Domingo, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0061 · Cited by 58
Garrahy, A., Sherlock, M., & Thompson, C. J. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0962 · Cited by 53
Yuen, K. C. J., Cook, D. M., Sahasranam, P., Patel, P., Ghods, D. E., Shahinian, H. K., & Friedman, T. C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03201.x · Cited by 53
Self-citationMarzullo, P., Marcassa, C., Campini, R., Eleuteri, E., Minocci, A., Priano, L., Temporelli, P. L., Sartório, A., Vettor, R., Liuzzi, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0829 · Cited by 52
“According to recent GH cutoff normative data obtained under arginine GHRH test in lean and obese subjects (23), biochemical criteria for GHD were fulfilled by 38% of our PWS”
MethodTritos, N. A., Yuen, K. C. J., & Kelly, D. F. (2015) · Endocrine Practice · doi:10.4158/ep14567.dscr · Cited by 51
Yuen, K. C. J., Biller, B. M. K., Katznelson, L. J., Rhoads, S. A., Gurel, M. H., Chu, O. S., Corazzini, V., Spiller, K., Gordon, M. B., Salvatori, R., et al. (2012) · Pituitary · doi:10.1007/s11102-012-0407-7 · Cited by 54
“Serum IGF-I levels were analyzed using methods previously described [16], and glucose levels were analyzed by a glucose analyzer (Beckman Glucose Analyzer; Fullerton, CA) at each participating center.”
MethodSelf-citationCurrent concepts of the diagnosis of adult growth hormone deficiency
Tritos, N. A., & Biller, B. M. K. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09594-1 · Cited by 55
Self-citationMakimura, H., Feldpausch, M. N., Rope, A. M., Hemphill, L. C., Torriani, M., Lee, H., & Grinspoon, S. K. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2794 · Cited by 48
Koutkia, P., Hron, B. M., Breu, J. J., & Grinspoon, S. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1342 · Cited by 49
The pituitary stalk effect: is it a passing phenomenon?
Bergsneider, M., Mirsadraei, L., Yong, W. H., Salamon, N., Linetsky, M., Wang, M. B., McArthur, D. L., & Heaney, A. P. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1386-5 · Cited by 50
Natural history of Rathke's cleft cysts: A retrospective analysis of a two centres experience
Sala, E., Moore, J. M., Amorin, A., Carosi, G., Martinez, H., Harsh, G. R., Arosio, M., Mantovani, G., & Katznelson, L. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13744 · Cited by 46
Grugni, G., Marzullo, P., Ragusa, L., Sartório, A., Trifirò, G., Liuzzi, A., Crinò, A., & on behalf of the Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02621.x · Cited by 47
Kelestimur, F., Popovic, V., Leal, A., Van Dam, P. S., Torres, E., Perez Mendez, L. F., Greenman, Y., Koppeschaar, H. P. F., Dieguez, C., & Casanueva, F. F. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02525.x · Cited by 45
Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury
Kreber, L. A., Griesbach, G. S., & Ashley, M. J. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4127 · Cited by 44
di Iorgi, N., Secco, A., Napoli, F., Tinelli, C., Calcagno, A., Fratangeli, N., Ambrosini, L., Rossi, A., Lorini, R., & Maghnie, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1081 · Cited by 44
IGF-I measurements in the diagnosis of adult growth hormone deficiency
Kwan, A. Y. M., & Hartman, M. L. (2007) · Pituitary · doi:10.1007/s11102-007-0028-8 · Cited by 45
“The authors concluded that an IGF-I level less than 77 lg/l may be useful for identification of patients with a very high probability of GH deficiency [41].”
Self-citationYang, A., Cho, S. Y., Kwak, M. J., Kim, S. J., Park, S. W., Jin, D., & Lee, J. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-52644-1 · Cited by 42
Kim, J. H., Chae, H. W., Chin, S. O., Ku, C. R., Park, K. H., Lim, D. J., Kim, K. J., Lim, J. S., Kim, G., Choi, Y. M., et al. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.272 · Cited by 52
“[13] compared five types of GH stimulation tests.”
BackgroundEffects of Oral Ingestion of Amino Acids and Proteins on the Somatotropic Axis
van Vught, A., Nieuwenhuizen, A. G., Brummer, R. J., & Westerterp‐Plantenga, M. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1784 · Cited by 42
“Therefore, the underlying mechanism of the increased GH release after protein ingestion may be related to GH-secreting properties of insulin ( 7 , 17, 18) because increased insulin responses to protein or AA ingestion mayplayaroleintheobservedGHresponses(19,20).Thiseffect is independent of plasma glucose responses, wh…”
BackgroundMethodMakimura, H., Stanley, T. L., Mun, D., Chen, C. S., Wei, J., Connelly, J. M., Hemphill, L., & Grinspoon, S. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1295 · Cited by 45
Metadata
- Authors
- Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L.
- Affiliations
- Harvard University (US)
- Oregon Health & Science University (US)
- University Hospitals of Cleveland (US)
- Cedars-Sinai Medical Center (US)
- NYU Langone Health (US)
- Corresponding author
- Biller, Beverly M. K.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-05-01
- Volume
- 87
- Issue
- 5
- Pages
- 2067-2079
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2125896595
- Semantic Scholar
- e5209f92424ddb2dfc412b4606bcb9a11bff13d5
- Cited by
- 423
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 25 · 2014: 17 · 2013: 19 · 2012: 17
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- insulin tolerance test, arginine stimulation test, GHRH stimulation test, diagnostic thresholds, sensitivity and specificity, multiple pituitary hormone deficiency, hypothalamic-pituitary disease, insulin-like growth factor I, diagnostic accuracy comparison, pituitary hormone replacement
- MeSH terms
- Adult, Aged, Aging, Arginine, Diagnostic Techniques, Endocrine, Drug Combinations, Female, Humans, Hypoglycemic Agents, Insulin, Insulin-Like Growth Factor I, Levodopa, Male, Metabolic Diseases, Middle Aged, Sensitivity and Specificity, Sex Characteristics, Growth Hormone-Releasing Hormone, Stimulation, Chemical, Body Mass Index, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.